Skip to main content

Research News

  • Oxygen-Boosted Microneedle Patch Shows Promise for More Effective Psoriasis Treatment

    Researchers have developed an innovative oxygen-boosted microneedle patch that significantly improves drug delivery and photodynamic therapy (PDT) for psoriasis, a chronic inflammatory skin disease that affects millions worldwide.

    The study, published in Acta Pharmaceutica Sinica B, describes a dual-section microneedle (MN) patch designed to overcome two major challenges in psoriasis treatment: poor drug penetration through thickened skin and reduced efficacy of PDT caused by low oxygen levels in inflamed lesions.

  • Wearable Bioelectronics Pave the Way for Future Personal Health Monitoring
    Wearable Bioelectronics Pave the Way for Future Personal Health Monitoring

    Advances in soft and sustainable wearable bioelectronics are set to transform personal health monitoring and digital healthcare, according to a new Perspective article published in BIO Integration. Researchers highlight how skin-like wearable systems can continuously track health signals during daily life, moving care beyond occasional hospital visits.

  • New research strengthens the potential of mycoprotein as an alternative to meat
    New research strengthens the potential of mycoprotein as an alternative to meat
    Researcher Ricky Wang delved into these issues and recently presented his findings in his doctoral thesis In vitro Gastrointestinal Fate of Edible Filamentous Fungi : Protein and Mineral Digestibility for Food Applications.
  • Blocking pain at the source : Hormone therapy rewires nerve signals in aging spines
    Blocking pain at the source : Hormone therapy rewires nerve signals in aging spines

    Low back pain (LBP) is one of the most common health problems worldwide, affecting people of all ages and placing a heavy burden on healthcare systems. Many patients experience persistent discomfort that interferes with work, sleep, and daily activities. Yet in most cases, doctors cannot identify a clear structural cause, making long-term treatment difficult.

  • Breakthrough in HIV Vaccine Research : Single-Shot Candidate Shows Neutralizing Success in Primates
    Breakthrough in HIV Vaccine Research : Single-Shot Candidate Shows Neutralizing Success in Primates
    Scientists at The Wistar Institute have reported a major step forward in HIV vaccine development with a novel vaccine candidate that can induce neutralizing antibodies after a single immunization in nonhuman primates, an achievement never before demonstrated in the field.
  • Wearable Hydrogel Breakthrough for Real-Time Cardio & Respiration Tracking
    Wearable Hydrogel Breakthrough for Real-Time Cardio & Respiration Tracking
    Scientists have developed an advanced MXene-based wearable hydrogel sensor capable of continuous heart rate and respiratory monitoring under extreme conditions such as high heat, humidity and vigorous exercise.
  • Scientists Decode How Cancer Cells Evade the Immune System, Opening Doors for Future Therapies
    Scientists Decode How Cancer Cells Evade the Immune System, Opening Doors for Future Therapies

    An international team of researchers has uncovered a crucial mechanism that allows certain cancer cells to hide from the body’s immune defenses, a discovery that could reshape future cancer treatments. The study, led by scientists at Julius-Maximilians-Universität Würzburg (JMU) in collaboration with partners in the United States, reveals how the powerful cancer-driving protein MYC not only fuels tumor growth but also helps tumors remain undetected by the immune system.

  • Heavy Lifetime Alcohol Use Linked to Higher Colorectal Cancer Risk, New Research Shows
    Heavy Lifetime Alcohol Use Linked to Higher Colorectal Cancer Risk, New Research Shows

    A new epidemiological study reported today finds that consistent heavy alcohol consumption over a lifetime is associated with a significantly increased risk of colorectal cancer, particularly rectal cancer, while reducing or quitting drinking may lower that risk. The findings were published online in the peer-reviewed journal Cancer.

  • New Gut Protein Intelectin-2 Shows Promise as Natural Antimicrobial Defender
    New Gut Protein Intelectin-2 Shows Promise as Natural Antimicrobial Defender
    Scientists have discovered an important protein in the human gut that can help protect the body from many harmful bacteria. This protein, called intelectin-2, acts as both a defensive barrier-builder and a bacteria-fighting molecule offering new insights into how the body defends itself at mucosal surfaces and pointing to possible future treatments against infections and antibiotic-resistant microbes.
  • Dual-Drug Breakthrough: A new pathway to treat Liver Fibrosis
    Dual-Drug Breakthrough: A new pathway to treat Liver Fibrosis
    Researchers have identified a promising new treatment strategy for liver fibrosis, a chronic condition that can lead to cirrhosis and liver cancer, by combining two well-known drugs. Preliminary findings suggest that using silybin together with carvedilol produces a powerful synergistic effect significantly stronger than either drug alone, against the cellular processes that drive scar tissue formation in the liver.
Subscribe to Research News